|
| | 103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB2631 Introduced 2/15/2023, by Rep. Marcus C. Evans, Jr. SYNOPSIS AS INTRODUCED:
|
| |
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List.
|
| |
| | A BILL FOR |
|
|
| | HB2631 | | LRB103 26141 KTG 52498 b |
|
|
| 1 | | AN ACT concerning public aid.
|
| 2 | | Be it enacted by the People of the State of Illinois,
|
| 3 | | represented in the General Assembly:
|
| 4 | | Section 5. The Illinois Public Aid Code is amended by |
| 5 | | adding Section 5-5.12f as follows:
|
| 6 | | (305 ILCS 5/5-5.12f new) |
| 7 | | Sec. 5-5.12f. Prescription drugs for hepatitis C virus; no |
| 8 | | prior approval mandates or utilization management controls. |
| 9 | | Notwithstanding any other provision of this Code to the |
| 10 | | contrary, for the purpose of removing barriers to the timely |
| 11 | | and equitable treatment of hepatitis C, prior authorization |
| 12 | | mandates and utilization management controls shall not be |
| 13 | | imposed under the fee-for-service and managed care medical |
| 14 | | assistance programs on any FDA-approved direct-acting |
| 15 | | antivirals for the treatment of hepatitis C that are listed as |
| 16 | | preferred on the Illinois Medicaid Preferred Drug List.
|